Cell Impact AB (publ) (STO:CI)

Cell Impact AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	39	47	100	133	830	2,072
Market Cap Growth	-49.94%	-52.36%	-25.18%	-83.97%	-59.93%	5.53%
Enterprise Value	55	62	119	143	666	2,035
Last Close Price	0.13	0.14	0.73	1.15	56.03	136.61
PS Ratio	6.89	8.34	2.63	2.79	10.60	25.33
PB Ratio	0.32	0.39	0.45	0.44	2.56	14.53
P/TBV Ratio	0.35	0.42	0.46	0.44	2.57	14.60
EV/Sales Ratio	9.66	10.94	3.13	3.00	8.51	24.88
Debt / Equity Ratio	0.22	0.22	0.14	0.14	0.14	0.14
Asset Turnover	0.03	0.03	0.12	0.12	0.25	0.34
Inventory Turnover	0.23	0.23	0.61	0.39	1.16	3.10
Quick Ratio	0.61	0.61	1.07	2.24	4.33	0.75
Current Ratio	2.02	2.02	3.03	3.58	5.43	1.60
Return on Equity (ROE)	-77.61%	-77.61%	-38.45%	-38.68%	-44.63%	-46.36%
Return on Assets (ROA)	-25.09%	-25.09%	-19.24%	-19.06%	-20.20%	-20.26%
Return on Capital Employed (ROCE)	-66.60%	-66.60%	-41.80%	-35.80%	-28.90%	-49.20%
Earnings Yield	-336.87%	-278.28%	-100.87%	-91.23%	-12.55%	-3.85%
FCF Yield	-120.70%	-99.71%	-74.96%	-117.44%	-20.28%	-6.71%
Buyback Yield / Dilution	-173.52%	-173.52%	-463.84%	-44.78%	-27.89%	-17.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.